Calls to poison centres about GLP-1 overdoses have climbed dramatically over the past few years. Health experts say the trend shows no sign of slowing down. In 2021, poison centres fielded around 100 calls a month linked to these medications. By 2025, however, that number had grown to roughly 1,000 calls every month. These figures reflect a sharp and worrying rise in GLP-1 overdoses. The increase has accompanied the explosive growth in the medication’s popularity for weight loss.

GLP-1 drugs, which include well known names such as Ozempic, Wegovy and Trulicity, originally treated diabetes. However, after regulators approved Wegovy for weight loss in 2021, demand surged dramatically. As many as one in eight adults now report taking a GLP-1 medication at some point. This widespread use has brought a corresponding rise in GLP-1 overdoses across the country.

What Happens During a GLP-1 Overdose

Indeed, the symptoms of a GLP-1 overdose can be severe and frightening. People affected have described uncontrollable vomiting, seizures and even vomiting blood. For instance, Karleigh McClain still experienced an elevated heart rate and vision problems a month later. Doctors had diagnosed her with a GLP-1 overdose. Similarly, model Lottie Moss ended up in hospital after she could not keep food or water down. She later suffered a seizure caused by dehydration.

Notably, these cases are not isolated incidents. For example, a seven year old girl in Indiana managed to inject herself with her mother’s medication. She ended up in hospital twice as a result. Her parents said she eventually began vomiting what appeared to be her stomach lining. Thankfully, she made a full recovery. Even so, her case shows how easily a weight loss jab overdose can occur when medication sits within reach of children.

Why Unregulated Access Is Driving GLP-1 Overdoses

A major factor behind the rise in GLP-1 overdoses is the growing availability of these medications through telehealth services. Equally, many of these platforms let people skip an in person doctor’s visit altogether. Some do not even require a consultation with a physician before issuing a prescription. This shortcut might feel convenient, but it removes important safeguards. Those safeguards exist specifically to prevent dosing errors and to catch adverse reactions early.

Furthermore, many telehealth providers supply compounded versions of these medications rather than the approved branded products. The FDA does not review compounded drugs for safety or effectiveness. In addition, the concentration of active ingredient can vary between suppliers. In February, the FDA sent warning letters to thirty telehealth companies. These companies had claimed their compounded products matched approved medications.

This lack of oversight carries real consequences. The FDA reported that many patients receiving compounded semaglutide had little or no experience with self administered injections. Confusion between millilitres, milligrams and units has contributed to dosing errors. As a result, some of these mistakes have led to severe weight loss jab overdoses requiring hospital treatment.

Recognising the Warning Signs of a Weight Loss Jab Overdose

Generally speaking, mild nausea, stomach discomfort and occasional vomiting count among the common and expected side effects of GLP-1 medications. Persistent vomiting, dizziness, confusion or an inability to keep fluids down, however, tells a different story. These symptoms can signal a genuine GLP-1 overdose that requires emergency care. Low blood sugar presents another serious risk, particularly when these medications combine with other diabetes drugs. In severe cases, it can cause shakiness, sweating and even loss of consciousness.

According to America’s Poison Centers, poison centres managed nearly 23,000 GLP-1 related exposure cases between 2019 and 2025. The organisation notes that most reported cases involve accidental therapeutic errors. Common examples include taking doses too close together or giving more than the recommended amount at once.

Preventing a GLP-1 Overdose Before It Happens

Avoiding a GLP-1 overdose starts long before any symptoms appear. Genuine medical supervision, rather than a rushed online form, makes a real difference. It gives a doctor the chance to assess whether the medication suits a patient. It also allows time to explain correct dosing and to watch for warning signs throughout treatment. Importantly, a doctor can properly consider any underlying health conditions before issuing a prescription.

Equally, experts encourage people to stay alert to red flags. These include prices that seem too good to be true, unusual packaging or any offer of a prescription without a genuine consultation. Storing medication securely and well away from children remains an essential step too. This matters given how easily young children have managed to access these drugs at home.

Ultimately, the rise in GLP-1 overdoses points to a wider need for caution. People need to think carefully about how they access and use these powerful medications. Choosing a properly regulated pathway, rather than a quick and unsupervised shortcut, remains the clearest way forward. It is also the surest way to avoid the serious harm that an overdose can cause.

Anyone concerned about a possible GLP-1 overdose should act quickly. This applies whether it involves their own health or someone else’s. Contact emergency services straight away, or call a poison control hotline for urgent guidance.

Source: dbrecoveryresources